Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies: Part 2 — An Interview with Dr Neel Pasricha on Adverse Event Management

<p>Dr Neel Pasricha from the University of California, San Franciso, reviews corneal and other ophthalmic toxicities associated with antibody-drug conjugates and other cancer therapies and strategies for their prevention and management.&nbsp;&nbsp;&nbsp;</p><p>CME information and select publications <a href="https://www.researchtopractice.com/InsideTheIssue2024/OcularToxicities/Part1" rel="noopener noreferrer" target="_blank">here</a>. </p>